Results 311 to 320 of about 297,791 (397)

Severe Vasoplegic Syndrome Treated with Angiotensin II and Hemoadsorption Therapy after Cardiac Surgery

open access: yesCatheterization and Cardiovascular Interventions, Volume 106, Issue 3, Page 1740-1745, September 1, 2025.
ABSTRACT Vasoplegic syndrome (VS) is a common complication after cardiac surgery with cardiopulmonary bypass (CPB). The main pathophysiology mechanism of VS includes a systemic inflammatory response syndrome due to surgical trauma, release of pro‐inflammatory mediators caused by blood contact with foreign surfaces of heart‐lung machine (pump and tubing)
Matteo Lucchelli   +3 more
wiley   +1 more source

Clinical outcomes of on-pump versus off-pump coronary-artery bypass surgery: a meta-analysis. [PDF]

open access: yesInt J Surg
He L   +7 more
europepmc   +1 more source

Transcatheter Aortic Valve Implantation in a Ross Procedure Patient With Severe Autograft Regurgitation: A Case Report

open access: yesCatheterization and Cardiovascular Interventions, Volume 106, Issue 3, Page 1946-1950, September 1, 2025.
ABSTRACT Surgical aortic valve replacement (AVR) is the standard treatment for symptomatic severe neo‐aortic regurgitation in Ross patients. The only previous report of a transcatheter aortic valve implantation (TAVI) in a Ross patient required valve‐in‐valve rescue. Thus, this is the first uncomplicated TAVI procedure in a Ross patient.
Anindya Mukherjee   +3 more
wiley   +1 more source

The Predictive Value of Quantitative Flow Ratio and Its Derived Angiographic Microvascular Resistance for Restenosis Following Drug‐Coated Balloon Angioplasty

open access: yesCatheterization and Cardiovascular Interventions, Volume 106, Issue 3, Page 1951-1957, September 1, 2025.
ABSTRACT Background Initially, drug‐coated balloon (DCB) angioplasty was primarily employed for in‐stent restenosis (ISR) treatment. Over time, its indications have broadened to include de novo small‐vessel lesions and bifurcation lesions. However, there is a lack of effective strategies to reduce restenosis rates post‐DCB angioplasty.
Chenhang Wang, Li Chen, Xiaoyong Xu
wiley   +1 more source

Impact of Femoropopliteal Drug‐Coated Balloon Use on Clinical Outcomes in Patients With Chronic Limb‐Threatening Ischemia

open access: yesCatheterization and Cardiovascular Interventions, Volume 106, Issue 3, Page 1993-2004, September 1, 2025.
ABSTRACT Background Drug‐coated balloons (DCBs) for femoropopliteal (FP) lesions have demonstrated superiority over standard percutaneous transluminal angioplasty (PTA) in maintaining vessel patency. However, data on whether the good durability of DCBs translates into improved wound outcome in chronic limb‐threatening ischemia (CLTI) patients are ...
Haruya Yamane   +11 more
wiley   +1 more source

Kawasaki Disease Presenting Uncommonly with Torticollis: A Case Report

open access: yesClinical Case Reports, Volume 13, Issue 9, September 2025.
ABSTRACT Kawasaki disease (KD) is an acute, febrile, systemic inflammatory disorder affecting children. A subset of KD patients, often infants or older children, does not meet the classic diagnostic criteria. In such cases, delayed recognition of atypical or incomplete KD can increase the risk of coronary artery complications.
Hassan Mottaghi Moghaddam Shahri   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy